151 related articles for article (PubMed ID: 18780574)
1. [Relapse in acute promyelocytic leukemia and the role of hematopoietic stem cell transplantation in the treatment of APL].
Zák P; Korístek Z
Vnitr Lek; 2008; 54(7-8):751-6. PubMed ID: 18780574
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of acute myeloid leukemias in the adult in relapse].
Thomas X; Le QH
Bull Cancer; 2002 Sep; 89(9):795-807. PubMed ID: 12368132
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
Fujita H; Nakaya A; Kato J; Tachibana T; Takemura S; Hyo R; Kawano T; Tanaka M; Taguchi J; Maruta A; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1095-9. PubMed ID: 16440769
[TBL] [Abstract][Full Text] [Related]
4. Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Tavernier E; Thomas X
Indian J Cancer; 2003; 40(4):140-3. PubMed ID: 14716110
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive review.
Kharfan-Dabaja MA; Abou Mourad YR; Fernandez HF; Pasquini MC; Santos ES
Biol Blood Marrow Transplant; 2007 Sep; 13(9):997-1004. PubMed ID: 17697961
[TBL] [Abstract][Full Text] [Related]
7. Curative therapeutic approaches to APL.
Tallmann MS
Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
9. Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia.
Ferrara F; Palmieri S; Annunziata M; Pocali B; Viola A; Pane F
Haematologica; 2004 May; 89(5):621-2. PubMed ID: 15136233
[TBL] [Abstract][Full Text] [Related]
10. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
[TBL] [Abstract][Full Text] [Related]
11. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
Korístek Z; Mayer J
Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia.
Termuhlen AM; Klopfenstein K; Olshefski R; Rosselet R; Yeager ND; Soni S; Gross TG
Pediatr Blood Cancer; 2008 Oct; 51(4):521-4. PubMed ID: 18493994
[TBL] [Abstract][Full Text] [Related]
13. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.
Yanada M; Yano S; Kanamori H; Gotoh M; Emi N; Watakabe K; Kurokawa M; Nishikawa A; Mori T; Tomita N; Murata M; Hashimoto H; Henzan H; Kanda Y; Sawa M; Kohno A; Atsuta Y; Ichinohe T; Takami A
Leuk Lymphoma; 2017 May; 58(5):1061-1067. PubMed ID: 27701911
[TBL] [Abstract][Full Text] [Related]
14. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA.
Ustün C; Arat M; Celebi H; Akan H; Ilhan O; Ozçelik T; Burgess RE; Koc H
Haematologica; 2001 Oct; 86(10):E31. PubMed ID: 11602438
[No Abstract] [Full Text] [Related]
15. Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia.
Hashmi H; Nishihori T
Clin Transplant; 2020 Sep; 34(9):e14009. PubMed ID: 32526047
[TBL] [Abstract][Full Text] [Related]
16. Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia.
Sanz MA; Tallman MS; Lo-Coco F
Oncologist; 2005; 10(10):806-14. PubMed ID: 16314291
[TBL] [Abstract][Full Text] [Related]
17. Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia.
Sanz MA; Lo Coco F
Haematologica; 2005 Jun; 90(6):840-5. PubMed ID: 15951298
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
19. Arsenic-induced APL differentiation in cerebrospinal fluid.
Helwig A; Klemm M; Schüttig R; Röllig C; Wassilew N; Ehninger G; Illmer T
Leuk Res; 2007 May; 31(5):703-5. PubMed ID: 16876245
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for relapsed acute promyelocytic leukaemia.
Estey EH
Best Pract Res Clin Haematol; 2003 Sep; 16(3):521-34. PubMed ID: 12935967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
